… genital warts, initial clearance rates, recurrence rates, and sustained clearance rates. This is
important because in the treatment of genital and perianal warts … of the present analysis, the …

… for use in economic evaluations, we sought … anogenital warts are caused by HPV-6 or -11,
7 we estimated the total lifetime cost that is associated with all new cases of anogenital warts …

… As HPV vaccination continues to gain widespread approval, … of HPV infection and
eventually eradicating genital warts. … Randomised controlled trial and economic evaluation of …

… We assumed the prophylactic efficacy of the vaccine against HPV 6-, 11-, 16- and 18-related
CIN and genital warts to be 95.2 and 98.9% respectively. Vaccination was assumed not to …

… As no exact date, but only the quarter was known for ambulatory diagnoses, it was not
possible to establish which medical practitioner diagnosed anogenital warts first in cases where …

… ), cancer and genital warts. In this economic evaluation, we evaluated the costeffectiveness …
, we conducted a scenario analysis that excluded the effect on genital warts, in order to both …

… Randomised controlled trial and economic evaluation of podophyllotoxin solution,
podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003;79:…

… US and worldwide, can cause cancers, anogenital warts (AGW), and recurrent respiratory
… meta-analysis indicated that genital warts decreased significantly by 31%; stratified analysis …

… % of high-grade precancerous lesions and 90% of genital warts caused by HPV types 6/11. …
as well as over a million cases of genital warts avoided after 100 years. The new technology …

… apparent benign warts and low-grade … of genital warts, ie exophytic lesions of the anogenital
tract that are visible with the naked eye, including condylomata acuminata and papular warts…